Biosimilars Europe

September 29 - 30, 2016 - London UK

SMi Group

tarri@smi-online.co.uk
Phone:2078276000
Fax:2078276000

SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access. Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. OUR NOTABLE SPEAKER LINE-UP WILL INCLUDE: • Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd • Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH • Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group • Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd • Dr Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety • Joan O’Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority, Ireland WHY YOU NEED TO BE THERE IN 2016: • Hear how the evolving regulatory landscape and guidelines will impact on biosimilars • Overcome market access and commercialisation barriers • Assess market trends and align your business strategy on emerging markets • Technical updates on protein characterisation and analytical comparability to speed up data collection PREVIOUS ATTENDEE TESTIMONIALS: "Really wide range of topics" - Kantar Health "Rich in information and quality speakers" - Globyz Pharma "Great discussions, networking and education" - Apobiologix "Interesting mix of scientists, legal and commercial folk" - Allergan "Impressive - beat my expectations" – Teva

More Information